Please assess the completion status of the following clinical trial:

Trial Title: HPV Vaccination in Special Risk Groups: 5 Year Follow-up

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Females who participated in the initial HPV vaccine immunogenicity study in 2007.~Exclusion Criteria:~* Inability to provide informed consent

- Gender: FEMALE
- Minimum Age: 12 Years
- Maximum Age: 26 Years
- Healthy Volunteers: f

Study Arms:
- PRD patrients (Type: None): Children/adolescent females 12-26 years with a PRD such as JIA (Juvenile Idiopathic Arthritis) or SLE (Systemic Lupus Erythematosus)~Subgroups:~1. receiving immunosuppressant therapy~2. not on immunosuppressant therapy
- IBD patients (Type: None): Children/adolescent females 12-26 years diagnosed with IBD.~Subgroups:~3. receiving immunosuppressant therapy 4. not on immunosuppressant therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).